Atlas Trials

Nonsquamous Non-small Cell Lung Cancer

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Nonsquamous Non-small Cell Lung Cancer

RecordFirmDate
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy (NCT05338970)Daiichi Sankyo2022-07-08
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer (NCT04736173)Arcus Biosciences, Inc.2021-02-08
HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NCT04750083)Taizhou Hanzhong biomedical co. LTD2020-09-25
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer (NCT04262856)Arcus Biosciences, Inc.2020-05-28
Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study (NCT04716933)Merck Sharp & Dohme LLC2019-11-05
A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy. (NCT03863483)Xin-Hua Xu2019-03-26
Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006) (NCT03829319)Merck Sharp & Dohme LLC2019-03-25
A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy (NCT03830411)Xin-Hua Xu2019-03-13

Track Nonsquamous Non-small Cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.